vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and SOLAREDGE TECHNOLOGIES, INC. (SEDG). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $335.4M, roughly 1.1× SOLAREDGE TECHNOLOGIES, INC.). AdvanSix Inc. runs the higher net margin — -0.8% vs -39.4%, a 38.6% gap on every dollar of revenue. On growth, SOLAREDGE TECHNOLOGIES, INC. posted the faster year-over-year revenue change (70.9% vs 9.4%). SOLAREDGE TECHNOLOGIES, INC. produced more free cash flow last quarter ($43.3M vs $36.1M). Over the past eight quarters, SOLAREDGE TECHNOLOGIES, INC.'s revenue compounded faster (28.1% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
SolarEdge Technologies, Inc. is an Israeli company that developed a DC optimized inverter system.
ASIX vs SEDG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $335.4M |
| Net Profit | $-2.8M | $-132.1M |
| Gross Margin | 7.6% | 22.2% |
| Operating Margin | -0.7% | -14.4% |
| Net Margin | -0.8% | -39.4% |
| Revenue YoY | 9.4% | 70.9% |
| Net Profit YoY | -892.9% | 54.0% |
| EPS (diluted) | $-0.11 | $-2.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $335.4M | ||
| Q3 25 | $374.5M | $340.2M | ||
| Q2 25 | $410.0M | $289.4M | ||
| Q1 25 | $377.8M | $219.5M | ||
| Q4 24 | $329.1M | $196.2M | ||
| Q3 24 | $398.2M | $235.4M | ||
| Q2 24 | $453.5M | $265.4M | ||
| Q1 24 | $336.8M | $204.4M |
| Q4 25 | $-2.8M | $-132.1M | ||
| Q3 25 | $-2.6M | $-50.1M | ||
| Q2 25 | $31.4M | $-124.7M | ||
| Q1 25 | $23.3M | $-98.5M | ||
| Q4 24 | $352.0K | $-287.4M | ||
| Q3 24 | $22.3M | $-1.2B | ||
| Q2 24 | $38.9M | $-130.8M | ||
| Q1 24 | $-17.4M | $-157.3M |
| Q4 25 | 7.6% | 22.2% | ||
| Q3 25 | 6.8% | 21.2% | ||
| Q2 25 | 14.3% | 11.1% | ||
| Q1 25 | 14.2% | 8.0% | ||
| Q4 24 | 3.4% | -57.2% | ||
| Q3 24 | 14.4% | -309.1% | ||
| Q2 24 | 17.9% | -4.1% | ||
| Q1 24 | 0.9% | -12.8% |
| Q4 25 | -0.7% | -14.4% | ||
| Q3 25 | -0.9% | -10.3% | ||
| Q2 25 | 7.7% | -39.9% | ||
| Q1 25 | 7.7% | -46.8% | ||
| Q4 24 | -3.9% | -134.4% | ||
| Q3 24 | 7.5% | -471.8% | ||
| Q2 24 | 11.5% | -60.4% | ||
| Q1 24 | -7.0% | -85.0% |
| Q4 25 | -0.8% | -39.4% | ||
| Q3 25 | -0.7% | -14.7% | ||
| Q2 25 | 7.7% | -43.1% | ||
| Q1 25 | 6.2% | -44.9% | ||
| Q4 24 | 0.1% | -146.5% | ||
| Q3 24 | 5.6% | -522.8% | ||
| Q2 24 | 8.6% | -49.3% | ||
| Q1 24 | -5.2% | -77.0% |
| Q4 25 | $-0.11 | $-2.21 | ||
| Q3 25 | $-0.10 | $-0.84 | ||
| Q2 25 | $1.15 | $-2.13 | ||
| Q1 25 | $0.86 | $-1.70 | ||
| Q4 24 | $0.02 | $-5.00 | ||
| Q3 24 | $0.82 | $-21.58 | ||
| Q2 24 | $1.43 | $-2.31 | ||
| Q1 24 | $-0.65 | $-2.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $493.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $427.5M |
| Total Assets | $1.7B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $493.2M | ||
| Q3 25 | $23.7M | $498.6M | ||
| Q2 25 | $18.4M | $758.0M | ||
| Q1 25 | $8.3M | $651.6M | ||
| Q4 24 | $19.6M | $585.9M | ||
| Q3 24 | $17.3M | $678.8M | ||
| Q2 24 | $12.1M | $689.8M | ||
| Q1 24 | $20.6M | $680.6M |
| Q4 25 | $815.2M | $427.5M | ||
| Q3 25 | $818.2M | $479.8M | ||
| Q2 25 | $823.7M | $513.2M | ||
| Q1 25 | $794.4M | $594.2M | ||
| Q4 24 | $774.6M | $658.3M | ||
| Q3 24 | $766.4M | $930.9M | ||
| Q2 24 | $746.6M | $2.1B | ||
| Q1 24 | $713.2M | $2.2B |
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.6B | $2.5B | ||
| Q1 25 | $1.6B | $2.5B | ||
| Q4 24 | $1.6B | $2.6B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.5B | $3.9B | ||
| Q1 24 | $1.5B | $4.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $52.6M |
| Free Cash FlowOCF − Capex | $36.1M | $43.3M |
| FCF MarginFCF / Revenue | 10.0% | 12.9% |
| Capex IntensityCapex / Revenue | 7.7% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $80.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $52.6M | ||
| Q3 25 | $26.6M | $25.6M | ||
| Q2 25 | $21.1M | $-7.8M | ||
| Q1 25 | $11.4M | $33.8M | ||
| Q4 24 | $64.2M | $37.8M | ||
| Q3 24 | $57.3M | $-89.3M | ||
| Q2 24 | $50.2M | $-44.8M | ||
| Q1 24 | $-36.2M | $-217.0M |
| Q4 25 | $36.1M | $43.3M | ||
| Q3 25 | $66.0K | $22.8M | ||
| Q2 25 | $-7.2M | $-9.1M | ||
| Q1 25 | $-22.6M | $23.7M | ||
| Q4 24 | $29.8M | $25.5M | ||
| Q3 24 | $26.8M | $-136.7M | ||
| Q2 24 | $16.7M | $-67.0M | ||
| Q1 24 | $-71.6M | $-243.4M |
| Q4 25 | 10.0% | 12.9% | ||
| Q3 25 | 0.0% | 6.7% | ||
| Q2 25 | -1.7% | -3.1% | ||
| Q1 25 | -6.0% | 10.8% | ||
| Q4 24 | 9.1% | 13.0% | ||
| Q3 24 | 6.7% | -58.1% | ||
| Q2 24 | 3.7% | -25.2% | ||
| Q1 24 | -21.3% | -119.1% |
| Q4 25 | 7.7% | 2.8% | ||
| Q3 25 | 7.1% | 0.8% | ||
| Q2 25 | 6.9% | 0.4% | ||
| Q1 25 | 9.0% | 4.6% | ||
| Q4 24 | 10.4% | 6.2% | ||
| Q3 24 | 7.7% | 20.1% | ||
| Q2 24 | 7.4% | 8.4% | ||
| Q1 24 | 10.5% | 12.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
SEDG
| Other | $197.7M | 59% |
| Europe Except Netherlands | $99.4M | 30% |
| Others | $38.2M | 11% |
